1. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen D, DeCarlo A, Engler JA. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 1993. 4:197–250.
Article
2. Catterall JB, Cawston TE. Assays of matrix metalloproteinases (MMPs) and MMP inhibitors: bioassays and immunoassays applicable to cell culture medium, serum, and synovial fluid. Methods Mol Biol. 2003. 225:353–364.
Article
3. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther. 1996. 70:163–182.
Article
4. Chevalier X. Is a biological marker for osteoarthritis within reach? Rev Rhum Engl Ed. 1997. 64:562–577.
5. Clegg PD, Coughlan AR, Carter SD. Equine TIMP-1 and TIMP-2: Identification, activity and cellular sources. Equine Vet J. 1998. 30:416–423.
Article
6. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989. 84:678–685.
Article
7. Fox DB, Cook JL. Synovial fluid markers of osteoarthritis in dogs. J Am Vet Med Assoc. 2001. 219:756–761.
Article
8. Halleen JM, Räisänen S, Salo JJ, Reddy SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, Väänänen HK. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem. 1999. 274:22907–22910.
Article
9. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): Its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem. 2000. 48:219–228.
Article
10. Hegemann N, Kohn B, Brunnberg L, Schmidt MF. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage. 2002. 10:714–721.
Article
11. Janckila AJ, Simons RM, Yam LT. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin. Clin Chim Acta. 2004. 347:157–167.
Article
12. Kaija H, Alatalo SL, Halleen JM, Lindquist Y, Schneider G, Vaananen HK, Vihko P. Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent. Biochem Biophys Res Commun. 2002. 292:128–132.
Article
13. Klimiuk PA, Sierakowski S, Latosiewicz S, Latosiewicz R, Cylwik B, Skowronski J, Chweicko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology (Oxford). 2002. 41:78–87.
Article
14. Lee HB, Alam MR, Seol JW, Kim NS. Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in early stages of canine osteoarthritis. Vet Med (Praha). 2008. 53:214–220.
Article
15. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990. 6:121–125.
Article
16. Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 2004. 50:543–552.
Article
17. Muir P, Schamberger GM, Manley PA, Hao Z. Localization of cathepsin K and tartrate-resistant acid phosphatase in synovium and cranial cruciate ligament in dogs with cruciate disease. Vet Surg. 2005. 34:239–246.
Article
18. Ness MG, Abercromby RH, May C, Turner BM, Carmichael S. A survey of orthopaedic conditions in small animal veterinary practice in Britain. Vet Comp Orthop Traumatol. 1996. 9:43–52.
Article
19. Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990. 33:1466–1476.
Article
20. Roy RG, Wallace LJ, Johnston GR, Wickstrom SL. A retrospective evaluation of stifle osteoarthritis in dogs with bilateral medial patellar luxation and unilateral surgical repair. Vet Surg. 1992. 21:475–479.
Article
21. Salinardi BJ, Roush JK, Schermerhorn T, Mitchell KE. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs. Vet Comp Orthop Traumatol. 2006. 19:49–55.
Article
22. Sibille JC, Doi K, Aisen P. Hydroxyl radical formation and iron-binding proteins. Stimulation by the purple acid phosphatases. J Biol Chem. 1987. 262:59–62.
Article
23. Tsuboi H, Matsui Y, Hayashida K, Yamane S, Maeda-Tanimura M, Nampei A, Hashimoto J, Suzuki R, Yoshikawa H, Ochi T. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis. 2003. 62:196–203.
Article
24. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999. 30:795–802.
Article
25. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000. 59:455–461.
Article